tiprankstipranks
StemRIM Inc. (JP:4599)
:4599
Japanese Market
4599
StemRIM Inc.
RESEARCH TOOLSreports

StemRIM Inc. (4599) Stock News & Sentiment

0 Followers
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
Premium
Company Announcements
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
23d ago
4599
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
Premium
Company Announcements
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
25d ago
4599
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
Premium
Company Announcements
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
1M ago
4599
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
Premium
Company Announcements
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
2M ago
4599
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
Premium
Company Announcements
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
3M ago
4599
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
Premium
Company Announcements
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
4M ago
4599
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
Premium
Company Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
4M ago
4599
More JP:4599 News >

4599 News on the Web

StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
TipRanks News
Bullish
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
TipRanks News
Bearish
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
TipRanks News
Bullish
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
TipRanks News
Bullish
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
TipRanks News
Neutral
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
TipRanks News
Neutral
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
TipRanks News
Neutral
StemRIM Secures US Patent for Psoriasis Treatment
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4599’s Media Buzz Sentiment?
Currently, no data Available
What is JP:4599’s weekly average amount of articles?
Currently, no data Available
What is JP:4599’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
OMEROmeros
AGIOAgios Pharma
2273Gushengtang Holdings Limited
PALIPalisade Bio
LTRNLantern Pharma
Showing the stocks with the most bullish news sentiment over the past week